So we are targetting syphillis and gonorhea ,I think we may have a couple more people working in the lab ,seems a lot more irons in the fire.A patent for these two would be nice.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.